State-of-the-Art Cancer Immunotherapies

Int J Mol Sci. 2024 Feb 22;25(5):2532. doi: 10.3390/ijms25052532.

Hisashi Nagase¹, Takuma Kato^{2

3}, Takayuki Yoshimoto⁴

¹ Department of Parasitology, Shinshu University School of Medicine 3-1-1, Asahi, Matsumoto 390-8621, Japan.
² Department of Cellular and Molecular Immunology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu 514-8507, Japan.
³ Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
⁴ Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.

Abstract

Cancer immunotherapy is a type of cancer therapy utilizing the immune system to fight against tumors [...].

This research received no external funding.